Results from a small retrospective analysis of patients with upper tract urothelial carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium.
Fear of facing discriminatory behavior within the health care system, along with other factors, may keep members of the LGBTQIA+ community from receiving cancer diagnoses.
A patient details the compassionate support that she received from an oncology nurse while receiving back-to-back treatments for cancer.
A man describes his wife’s tireless efforts to advocate for people of color in the metastatic breast cancer field, where many still face disparities within care, inclusion in clinical trials and survival outcomes.
Dr. Rugo has led key breast cancer therapy trials and exudes a passion for serving patients.
When experiencing loss, always look forward and have hope.
Three nurses—Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, safety and advocacy.
Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell carcinoma.
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
A woman dedicates a poem to the experience of meeting a fellow breast cancer survivor.
The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer
Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of cholangiocarcinoma.
From her earliest childhood days, Tammy Allred, RN, OCN, had a vision for her future: to soothe and to heal.
The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.
While the summer months are the perfect time for outdoor activities with friends and family, it is crucial to protect yourself from skin cancer.
Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.
Here are four signs of your doctor not listening and four things I do when they don't listen to me.
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Noelle Paul has time to talk on the way home from her job as an oncology surgical nurse at Memorial Sloan Kettering Cancer Center in New York City.
An Extraordinary Healer article honoring LAUREN H. McMURRY, B.S.N., RN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]
Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.
C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.
Specialized hospital programs — with help from "The Who" rockers — support teens and young adults through cancer.
"Her goal is to improve the cancer experience and management of cancer as a chronic disease, extending those efforts into survivorship."
A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described "concierge" for molecular diagnostic testing, is giving patients with this hard-to-treat cancer the ability to determine the best course of treatment.